Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats

Epilepsia

Volumn 41, Issue 4, 2000, Pages 372-379

  Reissmüller, Elke ^a   Ebert, Ulrich ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Kindling; Pharmacoresistance

Indexed keywords

CARBAMAZEPINE; FOSPHENYTOIN SODIUM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; FEMALE; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0034113410     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00176.x     Document Type: Article

References (19)

1. Leppik IE, ed. Rational polypharmacy. Amsterdam: Elsevier, 1996.
2. Langtry HD, Gillis JC, Davis R. Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752-73.
3. Markind JE. Topiramate: a new antiepileptic drug. Am J Health-Syst Pharm 1998;55:554-62.
4. Shank RP, Gardocki JF, Vaught JL, et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994; 35:450-60.
5. Löscher W. Animal models of epilepsy and epileptic seizures. In: Eadie MJ, Vajda F, eds. Antiepileptic drugs: handbook of experimental pharmacology. Berlin: Springer, 1999:19-62.
6. Wauquier A, Zhou SD. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res 1996;24:73-7.
7. Amano K, Hamada K, Yagi K, Seino M. Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res 1998;31: 123-8.
8. Löscher W, Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J Pharmacol Exp Ther 1991;258:483-9.
9. Löscher W, Rundfeldt C, Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res 1993;15:207-19.
10. Löscher W. Animal models of intractable epilepsy. Prog Neurobiol 1997;53:239-58.
11. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. Sydney: Academic Press, 1998.
12. Racine RJ: Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogy Clin Neurophysiol 1972;32:281-94.
13. Freeman FG, Jarvis MF. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res Bull 1981;7:629-33.
14. Löscher W, Reissmüller E, Ebert U. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin. Epilepsy Res 1998;30:69-76.
15. Smith RD, Brown BS, Maher RW, Matier WL. Pharmacology of ACC-9653 (phenytoin prodrug). Epilepsia 1989;30(suppl 2):S15-21.
16. Rundfeldt C, Hönack D, Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 1990;29:845-51.
17. Hönack D, Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 1995;36: 763-71.
18. Rogawski MA, Porter RJ. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 1990;42:223-86.
19. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmaco-kinetics and mechanism of action. Epilepsia (in press).